Invasive cardiovascular needs in South Africa: a view from afar up close
October 19, 2018 | 10.4244/EIJV14I8A153
Showing 1-14 of 14 articles
Coronary interventions
Magmaris preliminary recommendation upon commercial launch: a consensus from the expert panel on 14 April 2016 September 18, 2016 | 10.4244/EIJV12I7A137
Coronary interventions
Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trial June 10, 2016 | 10.4244/EIJ-D-15-00371
Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III) trial: a randomised comparison between sirolimus-eluting stent implantation and zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
March 20, 2015 | 10.4244/EIJY14M08_07
Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI
February 20, 2014 | 10.4244/EIJV9I10A201
The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials
October 25, 2013 | 10.4244/EIJV9I6A115